AMSTERDAM, the Netherlands, Feb. 6, 2015 (GLOBE NEWSWIRE) -- uniQure to Present at the at the Leerink Partners Global Healthcare Conference
Amsterdam, the Netherlands, February 6, 2015 - uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the 2015 Leerink Partners Global Healthcare Conference February 11-12, 2015, to be held at the Waldorf Astoria New York, New York City, NY, USA.
Date: February 12, 2015
Time: 11:35 a.m. (ET)
Location: Waldorf Astoria New York, New York City, NY, USA
Speaking for uniQure: Joern Aldag, Chief Executive Officer
To access a simultaneous webcast of Mr. Aldag's presentation via the internet, log on to the "Events" section on the Media page of the uniQure website at http://www.uniqure.com/news/calendar-of-events/.
A replay of the webcast will be available from uniQure's website for 30 days following the conference. Mr. Aldag's presentation will be available for download in PDF format immediately following the conference presentation in the "Events" section of the Media page of uniQure's website at http://www.uniqure.com/news/calendar-of-events/.
uniQure is delivering on the promise of gene therapy through single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease-modifying therapies to patients with severe disorders. We are engaged in multiple partnerships and have obtained regulatory approval of our lead product, Glybera, in the European Union for a subset of patients with LPLD.
Direct : +31 20 240 6100
Main: +31 20 240 6000
MacDougall Biomedical Communications
Direct: +49 172 861 8540
Main: +49 89 2424 3494 or 1 781 235 3060